| Net Cash Provided by (Used in) Operating Activities |
$398,000 |
USD |
63% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$6,738,000 |
USD |
-11% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
$3,412,000 |
USD |
|
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
90,000,000 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Common Stock, Shares, Issued |
5,994,977 |
shares |
-2.6% |
Q3 2024 |
Q3 2024 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$9,752,000 |
USD |
1353% |
Q1 2024 |
Q1 2024 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$2,837,000 |
USD |
122% |
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Valuation Allowance |
$3,700,000 |
USD |
1133% |
Q3 2024 |
Q3 2024 |
| Depreciation |
$118,000 |
USD |
-7.8% |
Q1 2024 |
Q1 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$3,434,000 |
USD |
|
Q3 2024 |
Q3 2024 |
| Deferred Income Tax Expense (Benefit) |
$100,000 |
USD |
34% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Additional Paid in Capital |
$49,304,000 |
USD |
-1.2% |
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$6,700,000 |
USD |
-12% |
Q3 2024 |
Q3 2024 |
| Interest Expense |
$11,130,000 |
USD |
136% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |